Recent data indicating that overexpression of caveolin-1 as well as c-myc are relatively common features of advanced prostate cancer prompted us to test for potential cooperative interactions between caveolin-1 and c-myc that would be consistent with malignant progression. We used the well-characterized Rat1Amy-cER TM cells to show that the caveolin-1 gene is downregulated at the level of transcription by c-myc. By maintaining relatively high levels of caveolin-1 with an adenoviral vector or in stably transfected clones we show that caveolin-1 can suppress c-myc-induced apoptosis. Further we established human prostate cancer cell lines with the mycER TM construct and show that clones with increased caveolin-1 are more resistant to myc-induced apoptosis and have increased capacity for growth in soft agar when c-myc is activated. Oncogene (2000) 19, 3256 ± 3265.
Introduction
Genetic alterations that lead to increased c-myc levels are exceedingly common in human malignancies (Marcu et al., 1992) . The c-MYC protein is a transcription factor that can dimerize with Max to regulate the expression of numerous target genes (Dang, 1999; Grandori et al., 1997) . The induced or repressed activities of speci®c c-myc target genes involve the regulation of cell proliferation versus apoptosis which are conditional responses to c-myc expression (Dang, 1999; Evan and Littlewood, 1998) . The regulation of cmyc-induced apoptosis is of critical importance to the role of c-myc in malignant progression as neutralization of the apoptotic eects of c-myc is necessary for proliferative functions of c-myc to be fully manifest (Evan and Littlewood, 1998; Prendergast, 1999) . Speci®c oncogenes such as bcl-2 can cooperate with cmyc in certain malignancies through their anti-apoptotic eects (Adams and Cory, 1998) .
We have recently identi®ed and characterized the expression of a speci®c gene, caveolin-1 (Yang et al., 1998b) , that appears to manifest some properties of bcl-2 family genes within the context of prostate cancer (Thompson et al., 1999a,b) . Caveolin-1 is a major structural component of caveolae, invaginations of the plasma membrane and trans-Golgi network that have been implicated in sphingolipid-cholesterol transport and speci®c signal transduction pathways (Parton, 1996) . We determined that caveolin-1 is overexpressed in both mouse and human prostate cancer (Yang et al., 1998b) and is predictive of recurrence following surgery for presumed localized disease (Yang et al., 1999) . Using a series of metastatic androgen-resistant mouse prostate cancer cells, clones that were stably transfected with antisense caveolin-1 we demonstrated reduced levels of caveolin-1 protein triggered apoptosis following withdrawal of androgen in vitro and in vivo (Nasu et al., 1998) . Reintroduction of caveolin-1 with an adenovirus in a representative antisense clone substituted for the survival eects of testosterone in vitro (Nasu et al., 1998) . Two independent reports have correlated overexpression of caveolin-1 with a multidrug resistant phenotype independent of P-glycoprotein in human cancer cell lines from several dierent tumor types (Lavie et al., 1998; Yang et al., 1998a) . The recent reports associating caveolin-1 with drug resistance are generally consistent with the survival promoting functions we have demonstrated in prostate cancer cells. Many drugs including taxol can activate speci®c signal transduction pathways and recent reports also indicate that induction of apoptosis by agents that lead to intracellular Ca 2+ elevation also activate speci®c signal transduction cascades (Srivastava et al., 1999) . Numerous studies have shown that caveolin-1/caveolae may regulate multiple signal transduction pathways including mitogen and Ca 2+ activated kinases in a cell-and context-speci®c fashion (reviewed by Shaul and Anderson, 1998) . Therefore it's conceivable that apoptotic signals generated by extracellular stimuli or potential oncogenes intersect with caveolin-1 mediated activities at the level of signal transduction.
Since overexpression and ampli®cation of c-myc have been shown to be critical determinants of prostate cancer progression (Bubendorf et al., 1999; Nupponen et al., 1998; Qian et al., 1997; Sato et al., 1999; Thompson et al., 1989) we tested for possible interactions between caveolin-1 and c-myc that would be relevant to prostate cancer progression. The results of our studies using multiple ®broblast models indicated that caveolin-1 is down-regulated by c-myc at the level of transcription. This down-regulation required active protein synthesis suggesting an indirect mechanism. Further studies revealed that enforced expression of caveolin-1 suppressed c-myc-induced apoptosis in dierent cell types and under multiple conditions. Finally using a human prostate cancer cell model we show that caveolin-1 and c-myc cooperate to generate increased numbers of soft agar colonies in vitro.
Results

Caveolin-1 is down-regulated by c-myc
We ®rst considered whether caveolin-1 was regulated by c-myc. The c-mycER TM fusion protein is a wellestablished system for identifying c-myc target genes (Eilers et al., 1991) which are either up-or downregulated by c-myc. As reviewed by Dang (1999) , more than 30 c-myc regulated genes have been identi®ed and correlated with a myc-mediated phenotype such as apoptosis, proliferation or transformation. The number of genes identi®ed as up-regulated by c-myc through speci®c DNA binding regions for MYC-MAX dimers (E-boxes) have been more numerous than those repressed by c-myc. However, it has been suggested that genes that are suppressed by c-myc may actually be more important in regard to myc-mediated proliferation and transformation than the genes that are up-regulated (Claassen and Hann, 1999; Facchini and Penn, 1998) yet, the mechanism(s) that underlie c-myc gene repression are poorly de®ned.
The activation of c-myc with 4-hydroxytamoxifen (OHT) in con¯uent serum-starved Rat1AmycER TM cells produced a time dependent decrease of caveolin-1 protein (Figure 1 , top right panel). Serum deprivation without OHT also led to decreased levels of caveolin-1 protein but to a lesser extent than with OHT ( Figure 1 , top left panel). Interestingly, a transient increase was consistently observed at 32 ± 36 h after media change with or without OHT. The c-myc speci®city of this response was con®rmed in parental Rat1A cells which when treated similarly had no decrease in caveolin-1 protein ( Figure 1a , middle panel). In a parallel experiment, induction of expression of c-myc from a tetracycline repressed promoter in Rat15TetMyc cells (Helbing et al., 1998 ) also led to a time dependent downregulation of caveolin-1 protein (Figure 1 , bottom panel). These results con®rm that c-myc expression leads to down-regulation of caveolin-1 protein. They further demonstrate that caveolin-1 protein levels are exquisitely sensitive to serum levels and nutrient conditions. Previous studies have also shown that caveolin-1 protein levels are regulated by factors contained in serum (Galbiati et al., 1998; Lee et al., 1998) .
The identi®cation of c-myc target genes with the Myc-ER fusion protein is a well established system to con®rm that candidate genes are activated or repressed at the mRNA level by c-myc in either a direct or indirect mechanism. In Figure 2 we document that caveolin-1 mRNA is down-regulated by c-myc in starved Rat1AmycER
TM ®broblasts by activation of cmyc with OHT. Steady-state mRNA levels are low in serum starved cells (time 0) compared to cells near con¯uence in 10% serum (time 724) but transiently increase 4 h after replacing the media with fresh 0.1% serum, as observed with another gene transcriptionally down-regulated by c-myc, H-ferritin (Wu et al., 1999) . Caveolin-1 mRNA levels decrease at 8 and 12 h without or with OHT however treatment with OHT reduced the caveolin-1 mRNA levels by an additional 30% after 4 h relative to that in parallel cultures without OHT. The c-myc-induced down-regulation of caveolin-1 was dependent on new protein synthesis since cycloheximide treatment blocked OHT-induced cmyc down-regulation of caveolin-1 mRNA. Extended treatments (48 h) with cycloheximide were not analysed due to extensive cell death consistent with previous reports in Rat1AmycER TM cells (Evan et al., 1992; Ulrich et al., 1998) .
To determine if the down-regulation of caveolin-1 was the result of transcriptional regulation we cloned 721 bases of DNA upstream of the mouse caveolin-1 gene from a PAC library into a luciferase reporter plasmid and transfected it into Rat1AmycER TM cells. As shown in Figure 3 induction of c-myc in serum starved cells leads to dramatically decreased promoter activity in the caveolin-1 promoter-luciferase construct. The level of suppression of the caveolin-1 promoter was about sixfold when normalized for transfection eciency with a co-transfected CMV-b-galactosidase construct. Preliminary sequence analysis of the mouse caveolin-1 promoter region did not reveal a canonical E-box and the published sequence of the human caveolin-1 promoter (Bist et al., 1997) also does not contain an E-box. One potential DNA sequence involved in repression of genes by c-myc has been termed Inr (Roy et al., 1993; Li et al., 1994) , with the weak consensus sequence YYCAYYYYY. There is at least one such site in the mouse caveolin-1 promoter however its functional signi®cance remains to be resolved. The eect of cycloheximide on caveolin-1 mRNA levels suggests an indirect mechanism of repression by c-myc, however regulation of the caveolin-1 gene is likely to be complex and regulated by multiple factors in addition to c-myc. Further studies will be required for elucidation of the mechanism of repression.
It is of interest that decreased steady state levels of caveolin-1 protein have been reported in NIH3T3 cells transformed with the oncogenes ras or abl (Koleske et al., 1995) , neu (Engelman et al., 1997) , or ras+myc (Yang et al., 1998b) . In the case of ras-mediated downregulation of caveolin-1 it is conceivable that these activities occur through increased stabilization of myc as has been demonstrated in REF52 cells (Sears et al., 1999) . Overall, the data could suggest that downregulation of caveolin-1 by c-myc creates a permissive state for induction of apoptosis. Conversely if caveolin-1 levels were up-regulated as observed in prostate cancer (Nasu et al., 1998; Yang et al., 1998b Yang et al., , 1999 cmyc-induced apoptosis may be suppressed.
Caveolin-1 suppresses c-myc-induced apoptosis
To initially evaluate the potential role of caveolin-1 in apoptosis resistance we also used the well-characterized Rat1AmycER TM cells in which apoptosis can be reproducibly induced in con¯uent, serum-starved cells by treatment with OHT leads to c-myc-induced apoptosis (Eilers et al., 1989) . In this system speci®c cytokines, insulin-like growth factor and platelet derived growth factor, have been shown to be able to suppress apoptosis independent of their eects on cell cycle progression (Harrington et al., 1994) . To ensure that caveolin-1 expression could be enforced on cells during a time frame in which apoptosis could be TM (top panel) or Rat1A (middle panel) cells were allowed to grow to near con¯uence, serum-starved, and c-myc activated with OHT. Rat15tet/myc (bottom panel) cells, a clone of Rat1 cells with a tetracycline-regulated c-myc construct (Helbing et al., 1998) , were reseeded with or without tetracycline. Caveolin-1 levels were consistently down-regulated by c-myc. Interestingly, a transient increase was consistently observed at 32 ± 36 h after media change with or without OHT Caveolin-1 suppresses c-myc-induced apoptosis TL Timme et al of caveolin-1 protein by c-myc was similar in the AdRSV infected cells to uninfected cells (compare with Figure 1 ). Several methods were used to determine whether caveolin-1 could suppress c-myc-induced apoptosis under these conditions. The number of cells that became permeable to trypan blue was evaluated microscopically at various times after OHT and a maximal response was observed at 48 h as illustrated in Figure 4b . The total number of cells increased by almost twofold in the OHT treated cells (not shown), however overall cell viability decreased over time in the OHT treated AdRSV 1X-infected cultures, whereas AdCav-1 1X-infected cultures did not lose cell viability relative to the level of apoptosis. Minimal growth over the same time period was observed in control treated (no OHT) cells following infection with either virus. The suppression of apoptosis by caveolin-1 was also documented by¯ow cytometry after binding of annexin V to cells infected with adenovirus (2X) and then treated with OHT for 48 h (Figure 4c ). In concordance with a previous report (Kangas et al., 1998) , we observed a low percentage of cells that had characteristics of early apoptosis (annexin V positive and propidium iodide negative), even at time points earlier than 48 h. The majority of apoptotic cells were positive for both annexin V and propidium iodide. It is interesting that the protection from apoptosis by caveolin-1 was obtained at low (5 ± 25) multiplicities of infection (MOI) but not at high MOIs (data not shown). We have observed a similar eect on survival in response to testosterone withdrawal in androgen sensitive mouse and human prostate cancer cell lines (Li et al. submitted) .
As an independent means of evaluating the eect of caveolin-1 over expression on apoptosis we transfected Rat1AmycER TM cells with either pBABEHygro or pBABECavHygro and established single colony clones. Clonal variation in the steady state level of caveolin-1 protein was noted but the clones expressing ectopic caveolin-1 (BC2, BC3, BC4 and BC7, Figure 5a ) maintained a higher level of caveolin-1 protein after OHT treatment compared the control clones (BH3 and BH5, Figure 5a ). To quantitate apoptosis we stained cells with DAPI and counted the percentage of cells The membrane was blotted with a mouse caveolin-1 cDNA or a rat GAPDH probe (Yang et al., 1998b) . The abundance of caveolin-1 mRNA was calculated from the ratio of caveolin-1 to 28S and compared to the abundance in the control cultures (without OHT) at each time point Figure 3 The luciferase plasmid pGL3-Basic or pGL3-mCav (7721) was transfected into Rat1AmycER TM cells along with pCMV-b-galactosidase. The day after transfection the cells were serum-starved for 24 h then c-myc activated with OHT. Luciferase levels were standardized to the level of b-galactosidase activity. The level of b-galactosidase decreased by less than twofold in the OHT treated cells as has been previously reported (Marhin et al., 1997) as did luciferase activity from a construct with an SV40 promoter (not shown), however the level of repression from the caveolin-1 promoter was about sixfold Oncogene Caveolin-1 suppresses c-myc-induced apoptosis TL Timme et al with a nuclear morphology characteristic of cells undergoing apoptosis (Figure 5b ). The caveolin-1 transfected clones that demonstrated an ability to maintain caveolin-1 protein levels after OHT treatment also had reduced apoptosis relative to vector control clones or parental Rat1AmycER TM cells (Figure 5c ).
Caveolin-1 suppresses c-myc-induced apoptosis in a human prostate cancer cell line
To extend these studies to a system more relevant to human cancer we transfected the pBABEmycER TM plasmid (Littlewood et al., 1995) and a control pBABEpuro plasmid into the prostate cancer cell line LNCaP which does not express detectable levels of caveolin-1 (Yang et al., 1998b) or a single colony derivative of it (LNCaP2A) that was established by transfection with a human caveolin-1 expressing plasmid (Figure 6a inset ). An additional clonal isolate (LNCaP2C) that demonstrated signi®cantly higher levels of caveolin-1 grew poorly and was not used for these studies. Evaluation of either pooled transfectants (Figure 6a ) or single colony isolates (not shown) revealed that LNCaPmycER TM cells were more sensitive to c-myc-induced apoptosis than the caveolin-1 expressing LNCaP2A cells with mycER TM or to control pBABEpuro transfectants when evaluated by DAPI staining or by¯ow cytometry after annexin V binding (not shown). Adenoviral vector infection with AdRSV of a clone of LNCaPmycER TM also con®rmed that Cells were serum-starved in 0.1 ± 0.03% CD-FBS for at least 24 h and apoptosis induced with OHT. After 48 h the cells oating in the media and those released by trypsin were collected, counted, and analysed for apoptosis by FACS following staining with Annexin V and propidium iodide. The fraction of all annexin V positive cells is reported as per cent of apoptotic cells. As previously shown the per cent of cells which were annexin V positive but propidium iodide negative was a small proportion of the apoptotic cells (Kangas et al., 1998) Caveolin-1 suppresses c-myc-induced apoptosis TL Timme et al caveolin-1 is not expressed in these LNCaP cells but can be ectopically expressed with the AdCav-1 vector (Figure 6b, inset) . This enforced expression of caveolin-1 suppressed c-myc-induced apoptosis as assessed by DAPI staining (Figure 6b ).
Caveolin-1 and c-myc cooperate to enhance the malignant features of prostate cancer
The LNCaPmycER TM model system was also used to evaluate the eect of caveolin-1 on colony formation in soft agar. It has been demonstrated that Rat1A ®broblasts with mycER TM activation have a 45-fold increase in the ability to form colonies in soft agar (Eilers et al., 1989) . As shown in Figure 7 the activation of c-myc led to a more than threefold increase in soft agar colonies in the caveolin-1 clone LNCaP2AMycER TM but no increase in LNCaPMycER TM cells. Thus ectopic caveolin-1 expression led to increased c-myc-induced growth functions in soft agar.
Discussion
In recent years a profound appreciation of the functional loss of speci®c apoptotic pathways in malignant progression and the ability of cancer cells to survive in the absence of their normal growth factor milieu has become manifest in both basic and clinical oncology research. Indeed, recent studies have clearly shown that many oncogenes and tumor suppressor genes are bipotential in that they demonstrate both growth promoting activities as well as pro-apoptotic functions depending on the cellular context (reviewed by Evan and Littlewood, 1998) . Therefore, it is apparent that the expression of genes that are directly involved in apoptotic pathways and that modify the activities of these pathways are critical to malignant progression.
Our previous work has identi®ed the relevance of caveolin-1 expression to prostate cancer progression. We initially identi®ed this gene as being up-regulated in both mouse and human prostate cancer metastases (Yang et al., 1998b) and subsequently demonstrated that its expression had independent predictive value in regard to progression of prostate cancer clinically (Yang et al., 1999) . We further identi®ed one aspect of the functional signi®cance of caveolin-1 expression in demonstrating that caveolin-1 expression could, in part, substitute for testosterone in regard to promoting survival of prostate cancer cells in vitro and in vivo (Nasu et al., 1998) . These studies have provided a foundation for further exploration of the signi®cance of caveolin-1 expression in prostate cancer and potentially other malignancies. In the course of these studies, we also observed that exceedingly high levels of caveolin-1 produced growth suppressive eects under certain conditions (e.g., clone LNCaP2C and unpublished data). Indeed, it has been suggested that caveolin-1 is a tumor suppressor gene based on growth suppressive activities in speci®c cell lines (Galbiati et al., 1998; Lee et al., 1998) . However, extensive LOH and mutation analysis of the caveolin-1 gene (Hurlstone et al., 1999) (and our unpublished observations) have not identi®ed genetic alterations consistent with tumor suppressor activity.
Overall, the collection of correlational observations and functional activities associated with caveolin-1 leads to comparison with the bcl-2 gene family. Bcl-2 and other family members not only manifest many anti-apoptotic functions, but can also block entry into the cell cycle and thus inhibit growth (Vairo et al., 1996) . These activities are well documented in the myelomonocyte progenitor cell system where bcl-2 can potentiate cell cycle arrest and the irreversible withdrawal into the nonproliferating (G0) state. Further studies also demonstrate that low levels of bcl-2 protein exhibit anti-apoptotic activities, yet high levels of bcl-2 can lead to pro-apoptotic activities in human glioma Figure 6 Caveolin-1 protects from c-myc-induced apoptosis in human prostate cancer cells. (a) LNCaP cells were transfected with a plasmid expressing the human caveolin-1 cDNA and stable G418 resistant clones isolated. Parental LNCaP cells had undetectable levels of caveolin-1 as previously described (Yang et al., 1998b) , clone 2A expressed low levels of caveolin-1 and clone 2C expressed high levels of protein (inset). Parental LNCaP cells and clone 2A were transfected with either pBABEPuro or pBABEmycER TM and cells selected in puromycin. Pools of transfectants (shown) as well as ring cloned single colony isolates (not shown) were tested for apoptosis induction by addition of OHT. Cells were stained with DAPI and the percentage of cells with nuclear condensation characteristic of apoptosis counted. (b) Adenovirus infection (AdCav-1) of LNCaPmycER TM cells at an MOI of 10 produced detectable levels of caveolin-1 protein (inset), and suppressed c-myc-induced apoptosis relative to uninfected or control virus (AdRSV) infected cells when detected by counting pyknotic cells after DAPI staining Figure 7 Caveolin-1 enhances c-myc-induced soft agar growth. Cells were trypsinized and seeded in 0.5% soft agar in RPMI 1640 with or without 100 nM OHT. Colonies were counted after 3 weeks and represent the average of three wells from a duplicated experiment Caveolin-1 suppresses c-myc-induced apoptosis TL Timme et al cells (Shinoura et al., 1999) . These observations are highly similar to those that we and others have obtained through overexpression of caveolin-1 in prostate cancer cells as well as in ®broblast systems.
In the present study, we further explored comparisons to bcl-2 in investigations that focused on interactions between c-myc and caveolin-1. We have demonstrated in multiple systems that overexpression of c-myc can lead to down-regulation of caveolin-1 through transcriptional regulation. This transcriptional down-regulation appeared to be indirect, as protein synthesis was required. Although the speci®c elements within the caveolin-1 promoter that mediate this inhibitory response have yet to be de®ned, there are potential sites that include an Inr element within the proximal region of the caveolin-1 promoter. It appears that caveolin-1 gene regulation occurs at multiple levels. Although there is clearly some regulation at the level of transcription that likely results in a reduction of steady state mRNA as we have shown, there appears to be additional mechanisms of regulating caveolin-1 mRNA that counteract these eects since the reduction in steady state mRNA is small compared to the suppression of caveolin-1 promoter activities by c-myc observed by transient transfection analysis. However, the level of reduction of caveolin-1 steady state mRNA (Figure 2 , 30% reduction at 4 h,) and the level of c-myc repression of caveolin-1 promoter activities by transient transfection analysis (Figure 3 , sixfold reduction at 24 h) cannot be directly compared due to fundamental dierences in the analyses. Unfortunately extended analysis of caveolin-1 steady state mRNA levels is precluded in this model because of extensive apoptosis. As caveolin-1 has been shown previously to be regulated by various serum factors (Galbiati et al., 1998; Lee et al., 1998 and see Figure 1 ), it is possible that either the growth of Rat1AmycER cells stimulated by c-myc and/or serum factors in the medium contribute to overall stability of caveolin-1 mRNA in this system. Caveolin-1 may also be regulated at the post-translational level by c-myc.
To further explore possible similarities with caveolin-1 and bcl-2, we demonstrated that overexpression of caveolin-1 can block c-myc-induced apoptosis in both ®broblast and prostate cancer cell line models. These eects led us to consider the potential for cooperative activities between caveolin-1 and c-myc in regard to the transformed phenotype. In additional studies, we demonstrated that caveolin-1 together with c-myc was capable of cooperating to generate enhanced numbers of colonies in soft agar in vitro relative to expression of c-myc alone or caveolin-1 alone. Overall, our studies establish interactive activities between c-myc and caveolin-1 that are consistent with cooperation during malignant progression in prostate cancer.
Additional studies will be required to clarify the mechanisms that underlie the protective eects of caveolin-1 within the context of c-myc stimulated apoptosis. With regard to bcl-2 the mechanism of protection from apoptosis induced by c-myc remains unclear (Prendergast, 1999) . It has been proposed that bcl-2 and speci®c cytokines such as IGF-1 suppress the initiation c-myc-induced apoptosis rather than aecting the kinetics of apoptosis (McCarthy et al., 1997) . One could speculate that caveolin-1 may interfere with the expression or functions of p53 and/or ARF/p19 which can be up-regulated in response to c-myc expression and have been shown to mediate c-myc-induced apoptosis in ®broblasts (Hermeking and Eick, 1994; Wagner et al., 1994; Zindy et al., 1998) . However, the capacity of these c-myc-regulated eectors to ultimately induce apoptosis likely depends on the capacity to activate the caspase protease cascade. Previous studies indicate that activation of PKB/Akt may regulate cmyc-induced apoptosis (Kaumann-Zeh et al., 1997) raising the possibility that caveolin-1 aects PKB/Akt or other levels of the survival pathway in which this kinase functions (Kaumann-Zeh et al., 1997) . A novel PKB/Akt-independent survival pathway for c-mycinduced apoptosis has also been reported for signaling through the nerve growth factor receptor TrkA (Ulrich et al., 1998) .
Overall our results establish that caveolin-1 is downregulated at the level of transcriptional repression by cmyc and that this down-regulation appears to be indirect. Further, when caveolin-1 is overexpressed in various ways c-myc-induced apoptosis is suppressed and phenotypic characteristics consistent with malignant progression are enhanced. As caveolin-1 and cmyc are overexpressed in advanced prostate cancer our ®ndings have obvious clinical relevance.
Materials and methods
Cells
The Rat1AmycER TM cell line and Rat1A cells were generously provided by Robert Eisenman of Washington University, Seattle, WA, USA. They were routinely grown in phenol red-free DMEM with 10% charcoal/dextran treated fetal bovine serum (CD-FBS) (Hyclone). Rat15tet/myc cells, a clone of Rat1 cells with a tetracycline-regulated c-myc construct (Helbing et al., 1998) , were grown in DMEM with 10% FBS in the presence of 2 mg/ml tetracycline to repress cmyc expression. LNCaP cells were obtained from the American Type Culture Collection, grown in RPMI 1640 with 10% FBS, and used at low passage (less than 60). LNCaP cells transfected with pBABEmycER TM or pBabePuro were grown in RPMI 1640 with 10% CD-FBS with 1 mg/ml puromycin and 2610 78 M testosterone.
c-myc activation
To activate c-myc, Rat1AmycER TM cells were allowed to grow to near con¯uence then the serum concentration reduced to 0.1 ± 0.03% for 24 ± 48 h. 4-hydroxytamoxifen (OHT) (Calbiochem) was dissolved in DMSO and added to media to give a ®nal concentration of 100 ± 250 nM. Control plates received an equal amount of DMSO. Rat15tet/myc cells were reseeded at 2610 4 cells/cm 2 with or without tetracycline. After 8 h the cells were washed twice with phosphate buered saline and the media replaced with DMEM with 0.1% FBS with or without tetracycline. The LNCaPmycER TM cells were seeded at 10 4 cells/cm 2 in RPMI 1640 with 10% FBS they were switched to RPMI 1640 supplemented with 2610 78 M testosterone without serum for 24 and then OHT added at 100 nM.
Plasmids and adenovirus
A fragment containing 721 nucleotides immediately upstream of the ATG codon of the mouse caveolin-1 gene was subcloned from a PAC clone. This mouse caveolin-1 Oncogene Caveolin-1 suppresses c-myc-induced apoptosis TL Timme et al promoter was inserted into the promoterless luciferase plasmid pGL3-Basic (Promega) to create pGL3-mCav (7721). Luciferase plasmids (2.0 mg) were transfected into Rat1AmycER TM cells using lipofectamine (Life Technologies) along with 0.5 mg of a plasmid with b-galactosidase under the control of the CMV promoter, pCMV-b-galactosidase. The day after transfection the cells were serum-starved for 24 h then c-myc activated with OHT. Cell lysates were prepared with reporter lysis buer (Promega) and luciferase assayed with LucLite (Packard Instruments) and standardized to the level of b-galactosidase activity. A mouse caveolin-1 cDNA was inserted into pBABEHygro, transfected into Rat1Amy-cER TM cells using lipofectamine and stable clones selected with 300 mg/ml hygromycin. A human caveolin-1 cDNA was inserted into pcDNA3.1 and transfected into LNCaP cells with lipofectamine. Stable clones were selected with 400 mg/ ml G418. pBABEPuro and pBABEmycER TM , also provided by Robert Eisenman, were transfected into LNCaP cells and stable colonies selected with 1 mg/ml puromycin.
An adenoviral vector with the human caveolin-1 cDNA (AdCav-1) was constructed as previously described (Nasu et al., 1998) . The control adenoviral vector without a cDNA insert (AdRSV) or AdCav-1 was used to infect Rat1Amy-cER TM cells 1 day after seeding at 3610 4 cells/cm 2 by adding virus at the indicated MOI to media without serum and leaving it on cells for 3 h. Additional media with serum was then added and the cells incubated for an additional day. In some experiments cells were infected twice with adenovirus by repeating the above infection 24 h after the ®rst. For apoptosis the cells were allowed to reach con¯uence then starved for 1 day and then treated with OHT for 2 days. Infection of LNCaPmycER TM was essentially as described above except at an MOI of 10 was used.
Western and Northern blots
Cells were scraped from culture plates and collected by centrifugation. The cell pellets were washed once with PBS and then lysed with TNES lysis buer (50 mM Tris (pH 7.5), 2 mM EDTA, 100 mM NaCl, 1% NP40, 20 mg/ml aprotinin, 20 mg/ml leupeptin and 1 mM PMSF) on ice for 45 min. Proteins were separated on a 15% polyacrylamide-SDS gel and then electrophoretically transferred onto a nitrocellulose membrane. Caveolin-1 was detected with polyclonal caveolin-1 antiserum (SC-894, Santa Cruz Biotech). A monoclonal bactin antibody (A5441, Sigma) was used to detect b-actin for loading control. Blots were visualized with Pierce Supersignal and the image captured with a Nucleovision camera. RNA was isolated from con¯uent Rat1AmycER TM at the indicated times. At time 724 the media was changed to 0.1% CD-FBS. At time 0 the media was changed again to 0.1% CD-FBS with or without OHT. RNA was isolated with UltraSpec (Biotecx Laboratories Inc) and 20 mg separated on a 1% SeaKem agarose gel, photographed, then transferred to nitrocellulose. The membrane was blotted with a mouse caveolin-1 cDNA or a rat GAPDH probe (Yang et al., 1998b) .
Apoptosis detection
The per cent of dead cells was determined by countinḡ oating plus cells detached by trypsinization which were unable to exclude trypan blue. Detection of annexin V and propidium iodide stained cells was after 48 h of OHT treatment. The cells¯oating in the media and those released by trypsin were collected and counted. An aliquot of 5610 5 was analysed for apoptosis by FACS following staining with Annexin V and propidium iodide (Oncogene Sciences). Direct counting of apoptotic cells was done following staining with 10 mg/ml bisbenzimide (DAPI). Cells with pyknotic or fragmented nuclei were counted as apoptotic.
Soft agar growth
Cells were trypsinized, counted and diluted to yield 1000 ± 2500 cells per 6 well. The cells were mixed with molten agarose in RPMI 1640 with 10% CD-FBS to give a ®nal agarose concentration of 0.5%. They were immediately layered on a base of 2% agar containing medium. The soft agar was allowed to solidify and then overlayed with an additional of 0.5% agarose overlay. OHT was included in the soft agar and overlaying media at 100 nM. After solidi®ca-tion, additional media was added and the plates incubated for 3 weeks.
